Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma-Reference-Cited by-同舟云学术

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma

Published:2017-05-03 Issue:3 Volume:178 Page:427-433
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Epperla Narendranath¹^ORCID,Pham Anthony Q.²,Burnette Brian L.²,Wiseman Gregory A.³,Habermann Thomas M.²,Macon William R.⁴,Ansell Stephen M.²,Inwards David J.²,Micallef Ivana N.²,Johnston Patrick B.²,Markovic Svetomir N.²,Porrata Luis F.²,Colgan Joseph P.²,Ristow Kay M.²,Nowakowski Grzegorz S.²,Witzig Thomas E.²

Affiliation:

1. Department of Hematology/Oncology; Medical College of Wisconsin; Milwaukee WI USA

2. Department of Hematology; Mayo Clinic; Rochester MN USA

3. Department of Radiology; Mayo Clinic; Rochester MN USA

4. Department of Pathology and Laboratory Medicine; Mayo Clinic; Rochester MN USA

Funder

Henry J Predolin Foundation

University of Iowa

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14688/fullpdf

Reference39 articles.

1. Ionizing radiation-induced instant pairing of heterochromatin of homologous chromosomes in human cells;Abdel-Halim;Cytogenetics and Genome Research,2004

2. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma;Al-Tourah;Journal of Clinical Oncology,2008

3. Transformation of follicular lymphoma in the era of immunochemotherapy: a population-based study from British Columbia;Al-Tourah;Journal of Clinical Oncology,2012

4. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients;Bastion;Journal of Clinical Oncology,1997

5. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab;Bennett;Blood,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-Cell Lymphoma not Otherwise Specified, Two Years after Oesophageal Cancer: A Case Report;Indian Journal of Dermatology;2024-03

2. A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma;The Oncologist;2024-01-11

3. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study;Annals of Hematology;2023-03-30

4. Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors;Annals of Hematology;2023-01-09

5. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-08